Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
06/2003
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/05/2003WO2003046034A2 Improved synthesis of polyanhyrides
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003US20030105353 Process for the arylation of olefins
06/05/2003US20030105351 Method for producing lysine derivative
06/05/2003US20030105280 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy -carbonyl)phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation
06/05/2003US20030105164 Reacting hexachloroacetone with triphenylphosphine; chlorination of retinoic acid; then aromatic amine; anticancer agents
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030103905 Methods and compositions for preparing consumables with optical shifting properties
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/05/2003CA2466039A1 Improved synthesis of polyanhydrides
06/04/2003EP1315695A2 Benzene tricarboxylic acid amides as insulin receptor activators
06/04/2003EP1315694A2 Inhibitors of alpha 4 mediated cell adhesion
06/04/2003EP1045829B1 Method for producing n-(3-amino-4-fluorophenyl)- sulphonamides, n-(3-amino-4-fluorophenyl) carboxylic acid amides and n-(3-amino-4-fluorophenyl) carbamates
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0966429B1 Valnoctamide stereoisomers, a method for their synthesis and separation and uses thereof
06/04/2003EP0862545B1 Pesticide compounds, compositions and process for the preparation thereof
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/03/2003US6573398 Such as (Z)-4-(tert-butylamino)-4-oxo-2-butenoic acid; protective coatings for use as two-part liquid pavement markings
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
05/2003
05/30/2003WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003WO2003043624A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
05/30/2003WO2002094765A3 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
05/30/2003WO2002070020A3 Polymer precursors of radiolabeled compounds, and methods of making and using the same
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/29/2003US20030100790 Such as N-formyl-D,L-alanine methyl ester by reacting butyl formate with alanine; by product inhibition
05/29/2003US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/28/2003EP1314720A1 Process for the production of crystals of a benzoic acid derivative
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314718A1 Quaternised fatty acid amidoamines
05/28/2003EP1314717A1 Method for preparing N-long chain acyl neutral amino acid
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1313547A2 Liquid membrane separation of enantiomers
05/28/2003EP1206427A4 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
05/28/2003EP1021396B1 Polyalkanolamide tackifying resins for creping adhesives
05/28/2003EP0977727B1 Process for making carboxylic amides
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003EP0966516B1 Method for producing neutral sugar surfactant granulates
05/28/2003EP0946280B1 Method for carrying out reactions characterized by an equilibirum
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6570037 Reacting a primary amine derivative containing another secondary or tertiary amine with a nitrobenzene containing carbonyl halide group
05/27/2003US6569899 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
05/27/2003US6569829 Removing impurities from a long chain N-acyl acidic amino acid such as N-lauroyl-L-glutamic acid containing an inorganic salt by solvent extraction using a solution of water and tert-butanol; use in cosmetics and detergents
05/27/2003US6569411 Deodoring, microbiocides, marking odors
05/22/2003WO2003042166A2 PROCESS FOR PREPARATION OF α-HYDROXYCARBOXYLIC ACID AMIDES
05/22/2003WO2003042165A1 Formoterol tartrate process and polymorph
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042135A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003WO2002095393A3 Drug evolution: drug design at hot spots
05/22/2003WO2002083120A3 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
05/22/2003WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030097019 T-butyl cascade polymers
05/22/2003US20030097005 Method for the preparation of enantiomerically enriched compounds
05/22/2003US20030097002 Enantioselective reactions using two-component chiral phase transfer catalysts in multiphasic systems
05/22/2003US20030096996 Process for producing organotitanium compound and process for addition reaction
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096847 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096802 Pentanoic acid derivatives
05/22/2003CA2724716A1 Process for preparation of .alpha.-hydroxycarboxylic acid amides
05/22/2003CA2477642A1 Formoterol tartrate process and polymorph
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466449A1 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1311517A1 Cycloaliphatic/aromatic diphosphines and use thereof in catalysis
05/21/2003EP1311480A1 New amidino derivatives and their use as thrombin inhibitors
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311158A1 Composition having insect repellent characteristics
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003CN1419535A Method for producing n-butyryl-4-amino-3-methyl-methyl benzoate and the novel compound n-(4-bromine-2-methylphenyl)-butanamide
05/21/2003CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/21/2003CN1109016C Synthetic polyunsaturated fatty acid analogues
05/21/2003CN1108796C Use of anticancer material and production method of said anti-cancer material
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566553 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline
05/20/2003US6566547 Fungicides
05/20/2003US6566546 Reacting of phenylboronic acids with 4- bromo- or 4-iodo-alkyl- or -alkoxy-anilines or -anilides, possible deacylation and diazotization, followed by reaction with a nucleophile by sandmeyer reaction or a reducing agent
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566409 Lock and key micelles
05/20/2003US6566403 For controlling phytopathological fungi
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040149A2 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039456A2 Process for the preparation of aniline-derived thyroid receptor ligands
05/15/2003WO2003005965A3 Modulators of ceramidase and methods of use based thereon
05/15/2003WO2002053537A8 Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
05/15/2003US20030092946 Protecting the hydroxy group by means of a sulphonic ester function; reacting the protected phenolic compound with an electrophilic reactant; deprotecting the hydroxy group
05/15/2003US20030092828 Fluorine-containing compounds and polymers derived therefrom